Circulating endothelial progenitor cells as biomarker for anti-angiogenic therapy with sunitinib and docetaxel in prostate cancer patients. Antitumor activity of sequential treatment with tyrosine ...

Portrait of sick elderly caucasian man holding pill glass of water at home on the sofa. Depressed unhealthy man, about to take antidepressant pill, emergency contraceptive, painkiller for painful ...

Black men with metastatic hormone-sensitive prostate cancer may have better outcomes if they receive enzalutamide rather than bicalutamide in combination with androgen deprivation therapy, data from a ...

Carfilzomib for metastatic castration-resistant prostate cancer (mCRPC) following chemotherapy and androgen pathway inhibitors. Background: Responses to ADT in new HSPC are not durable and the disease ...

Adding hormone therapy to radiation therapy after surgery showed significant survival improvements in a recent study involving men with recurrent prostate cancer. Survival was improved in patients ...